Cagrilintide is a next-generation amylin analog peptide that has become one of the most researched compounds in the field of metabolic health and weight management.

Cagrilintide – 10mg

Cagrilintide: Advanced metabolic and weight-management research peptide , studied for its potential to reduce appetite, regulate glucose, and enhance energy balance.

$80.00

Cagrilintide is a next-generation amylin analog peptide that has become one of the most researched compounds in the field of metabolic health and weight management. As a long-acting version of the natural hormone amylin, this peptide works to regulate appetite, support glucose control, and reduce food cravings in preclinical studies.

Researchers are increasingly studying Cagrilintide both alone and in combination with GLP-1 receptor agonists such as semaglutide and tirzepatide, due to its potential to enhance satiety and amplify metabolic effects.

Key Research Highlights

May support healthy weight management through appetite regulation
Shown in studies to reduce caloric intake and promote fullness
Potential to complement GLP-1 analogs for synergistic effects
May help support glucose balance and metabolic function

Product Specifications

Form: Lyophilized powder
Purity: ≥ 99% (HPLC tested)
Storage: Store dry at 2–8 °C. After reconstitution, refrigerate and use within 20 days.
For Research Use Only. Not for human consumption.